2Li LS, Liu ZH. Epidemiologie data of renal diseases from a single unit in China: analysis based on 13,519 renal biopsies [J]. Kidney Int,2004,66(3) :920-923.
3d'Amico G. Natural history of idiopathic IgA nephropathy: role of clinical and histological prognostic factors[J]. Am J Kidney Dis,2000,36(2) :227-237.
4Camici M. Urinary detection of podocyte injury [J]. Biomed Pharmacother, 2007,61 (5) : 245-249.
5Vogelmann SU, Nelson WJ, Myers BD, et al. Urinary excretion of viable podocytes in health and renal disease[J]. Am J Physiol Renal Physiol,2003,285(1) :F40-48.
6Usui J, Yarnagata K, Kai H, et al. Heterogeneity of prognosis in adult IgA nephropathy,especially with mild proteinuria or mild histological features[J]. Intern Med, 2001,40 (8) : 697- 702.
7Sezto CC, Lai FM, To KF, et al. The natural history of immunoglobulin a nephropathy among patients with hematuria and minimal proteinuria[J]. Am J Med, 2001,110 (6) :434-437.
8Pozzi C, Andrullis S, Del Vecchio L, et al. Cortieosteroids Effectiveness in IgA nephropathy: long-term results of a randomised controlled trial[J]. J Am Soe Nephrol, 2004, 15 (1):157-163.
9Nakamura T, Ushiyama C, Hirokawa K, et al. Effect of cerivastatin on proteinuria and urinary podocytes in patients with chronic glomerulonephritis[J]. Nephrol Dial Transplant, 2002,17(5) : 798-802.
10Mathieson PW. Update on the podocyte[J]. Curr Opin Nephrol Hypertens, 2009,18(3) :206-211.
